Listen
Japanese
Contact

News

MHLW approves New Indication for OSELTAMIVIR Capsules 75 mg [SAWAI] / Dry Syrup 3% [SAWAI]

Jun. 06. 2018

Osaka, Japan – June 6 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) for OSELTAMIVIR Capsules 75mg [SAWAI] and OSELTAMIVIR Dry Syrup 3% [SAWAI]*.

This approval expands the indication of OSELTAMIVIR Capsules 75mg [SAWAI] and OSELTAMIVIR Dry Syrup 3% [SAWAI] to include the same uses as their brand equivalents.

* Brand products: TAMIFLU® Capsules 75mg and Dry Syrup 3%

“Indications and Usage” and “Dosage and Administration” after approvals are as below;

(1) OSELTAMIVIR Capsules 75 mg [SAWAI]

Indications and Usage (New approval is underlined) Treatment or prophylaxis of influenza type A or B virus infection
Dosage and Administration (New approval is underlined)
When used for treatment
In general, for adults, start taking 5 to 10mg of olanzapine at a time, once a day. The dosage is maintained on 10mg once a day, it may be adjusted according to your age and symptoms. However, the daily dosage should not exceed 20mg.
When used for prophylaxis
(1) Adults
In general, 75 mg as oseltamivir is administered orally once a day for 7 to 10 days.
(2) Children weighing 37.5 kg or more
In general, 75 mg as oseltamivir is administered orally once a day for 10 days.

(2) OSELTAMIVIR Dry Syrup 3%[SAWAI]

Indications and Usage (New approval is underlined) Treatment or prophylaxis of influenza type A or B virus infection
Dosage and Administration (New approval is underlined)
When used for treatment
(1) Adults
In general, 75 mg as oseltamivir is suspended before use and administered orally twice a day for 5 days.
(2) Children
In general, the dosage below is suspended before use and administered orally twice a day for 5 days. However, the maximum dose per administration is 75 mg as oseltamivir.
Children and young children: 2 mg/kg as oseltamivir (66.7 mg/kg as Dry Syrup)
Neonates and infants: 3 mg/kg as oseltamivir (100 mg/kg as Dry Syrup)
When used for prophylaxis
(1) Adults
In general, 75 mg as oseltamivir is suspended before use and administered orally once a day for 7 to 10 days.
(2) Children
In general, the dosage below is suspended before use and administered orally once a day for 10 days. However, the maximum dose per administration is 75 mg as oseltamivir.
Children and young children: 2 mg/kg as oseltamivir (66.7 mg/kg as Dry Syrup)